HEALTHSTORY 728· JULY 7, 2026

Vertex Pharmaceuticals to Buy Crinetics Pharmaceuticals for $10 Billion in Rare Disease Deal

Vertex Pharmaceuticals announced Monday it will acquire Crinetics Pharmaceuticals for $10 billion, or roughly $85 per share, adding a commercial rare-disease therapy and additional pipeline candidates to its portfolio. The deal centers on…

NDNewsDialy Desk2 MIN READ

SOURCE

statnews.com

← PREVIOUS STORY 727Fred Karlinsky of Greenberg Traurig Named Chair-Elect of Leadership Florida Board NEXT STORY 729 →UMD Smith School Study Says America's Infrastructure Gap Is a Design Problem, Not a Money Problem

Keep reading

More from the desk.

01HEALTH

Two patients who received pig kidneys have now gotten human transplants

Two people who received genetically engineered pig kidneys have now gone on to receive human donor organs, a result that suggests a temporary animal transplant does not block a conventional one later. A xenograft, the medical term for a…

health2 MIN

17HEALTH

FDA lets AI medical devices reach patients before full authorization under new TEMPO pilot

Some medical devices that use artificial intelligence to make care decisions can now reach patients before their makers have received marketing authorization, the formal federal clearance that normally must precede any commercial sale of a…

health2 MIN

24HEALTH

Doctors groups release vaccination guidelines ahead of respiratory illness season

Vaccination guidance for the coming winter respiratory season is now available for both medical professionals and their patients. The short version: a coalition of professional organizations representing pediatricians, family physicians…

health1 MIN

Tomorrow · 06:00

Start tomorrow already ahead.

Five stories, a two-minute read, zero noise — the world before your first coffee.

Get the 6AM brief Back to the desk